Why the study?
Does epicardial left ventricular lead placement provide similar benefits to transvenous placement in patients requiring cardiac resynchronization therapy?
Does epicardial left ventricular lead placement provide similar benefits to transvenous placement in patients requiring cardiac resynchronization therapy?
Epicardial lead placement is a viable and effective alternative for cardiac resynchronization therapy in patients with unsuccessful transvenous coronary sinus lead placement, yielding similar 6-month outcomes.
Answers are grounded in this paper and cite their sources.
Supports epicardial leads as alternative when transvenous fails; leaves open randomized confirmation of equivalence.
AIMS: Cardiac resynchronization therapy (CRT) is a recognized treatment for appropriate patients. However, placement of the transvenous left ventricular lead is unsuccessful in 5-10% of patients and a further 20% fail to respond. For these groups, epicardial left ventricular lead placement is one alternative. We prospectively evaluated the effects of epicardial vs. transvenous placed CRT. METHODS AND RESULTS: Twenty-three subjects with unsuccessful transvenous coronary sinus lead placement underwent epicardial implantation. The subjects underwent clinical evaluation, cardiopulmonary exercise testing, and echocardiography before 3 and 6 months after. The results were compared with a control group (n = 35) who had received transvenous CRT. In both groups, there were significant improvements in all measures at 3 and 6 months. The improvement in peak VO(2) was delayed in the epicardial group compared with the transvenous group. At 6 months, the improvements seen in all variables showed no difference between the groups. CONCLUSION: Epicardial lead placement is a viable option for patients with unsuccessful coronary sinus lead placement. The improvements in most variables were of a similar magnitude and over a similar time scale compared with transvenous placement. Improvements in peak VO(2) were delayed in the epicardial group, probably as a result of a prolonged recovery time.
No takes yet. Share an insight, caveat, or question.
Patwala et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: